Dr Neal Shore introduces the current global landscape of various imaging modalities for prostate cancer, including a new prostate-specific membrane antigen (PSMA)-targeted PET/CT agent, PYLARIFY® (piflufolastat F 18).
Standardizing oncology patient navigator role clarification can help nurses and social workers operate at the top of their license while protecting patient navigators and institutions from liability issues.
Creating patient navigation and survivorship programs to deliver SCPs can be challenging. Many clinical professionals are tasked with developing programs, but they may not possess the program-planning skills that are essential for success.
The Patient Navigation Framework: Navigator Function Across Domains will serve as a guide for developing patient navigation-specific competencies so the field of patient navigation can move toward greater standardization of the profession.